RAAS and SGLT2 Inhibitor combo increases survival in Patients with Albuminuric CKD without Diabetes
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok